Pan MR - Search Results

1

Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.

Lee HH, Wang YN, Yang WH, Xia W, Wei Y, Chan LC, Wang YH, Jiang Z, Xu S, Yao J, Qiu Y, Hsu YH, Hwang WL, Yan M, Cha JH, Hsu JL, Shen J, Ye Y, Wu X, Hou MF, Tseng LM, Wang SC, Pan MR, Yang CH, Wang YL, Yamaguchi H, Pang D, Hortobagyi GN, Yu D, Hung MC. Lee HH, et al. Among authors: pan mr. Nat Commun. 2021 May 13;12(1):2788. doi: 10.1038/s41467-021-23075-2. Nat Commun. 2021. PMID: 33986289 Free PMC article.

2

Cyclooxygenase-2 up-regulates CCR7 via EP2/EP4 receptor signaling pathways to enhance lymphatic invasion of breast cancer cells.

Pan MR, Hou MF, Chang HC, Hung WC. Pan MR, et al. J Biol Chem. 2008 Apr 25;283(17):11155-63. doi: 10.1074/jbc.M710038200. Epub 2008 Mar 4. J Biol Chem. 2008. PMID: 18319253 Free article.

3

Cyclooxygenase-2 up-regulates CCR7 expression via AKT-mediated phosphorylation and activation of Sp1 in breast cancer cells.

Chuang CW, Pan MR, Hou MF, Hung WC. Chuang CW, et al. Among authors: pan mr. J Cell Physiol. 2013 Feb;228(2):341-8. doi: 10.1002/jcp.24136. J Cell Physiol. 2013. PMID: 22718198

4

β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast Cancer.

Yin HL, Wu CC, Lin CH, Chai CY, Hou MF, Chang SJ, Tsai HP, Hung WC, Pan MR, Luo CW. Yin HL, et al. Among authors: pan mr. Int J Mol Sci. 2016 Aug 31;17(9):1432. doi: 10.3390/ijms17091432. Int J Mol Sci. 2016. PMID: 27589736 Free PMC article.

5

The NuRD complex-mediated p21 suppression facilitates chemoresistance in BRCA-proficient breast cancer.

Hou MF, Luo CW, Chang TM, Hung WC, Chen TY, Tsai YL, Chai CY, Pan MR. Hou MF, et al. Among authors: pan mr. Exp Cell Res. 2017 Oct 15;359(2):458-465. doi: 10.1016/j.yexcr.2017.08.029. Epub 2017 Aug 24. Exp Cell Res. 2017. PMID: 28842166

6

CHD4-mediated loss of E-cadherin determines metastatic ability in triple-negative breast cancer cells.

Luo CW, Wu CC, Chang SJ, Chang TM, Chen TY, Chai CY, Chang CL, Hou MF, Pan MR. Luo CW, et al. Among authors: pan mr. Exp Cell Res. 2018 Feb 1;363(1):65-72. doi: 10.1016/j.yexcr.2017.12.032. Epub 2018 Jan 3. Exp Cell Res. 2018. PMID: 29305962

7

FAK is Required for Tumor Metastasis-Related Fluid Microenvironment in Triple-Negative Breast Cancer.

Pan MR, Hou MF, Ou-Yang F, Wu CC, Chang SJ, Hung WC, Yip HK, Luo CW. Pan MR, et al. J Clin Med. 2019 Jan 2;8(1):38. doi: 10.3390/jcm8010038. J Clin Med. 2019. PMID: 30609732 Free PMC article.

8

Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics.

Ou-Yang F, Pan MR, Chang SJ, Wu CC, Fang SY, Li CL, Hou MF, Luo CW. Ou-Yang F, et al. Among authors: pan mr. Life Sci. 2019 Dec 1;238:116963. doi: 10.1016/j.lfs.2019.116963. Epub 2019 Oct 19. Life Sci. 2019. PMID: 31639396

9

Impact of FAK Expression on the Cytotoxic Effects of CIK Therapy in Triple-Negative Breast Cancer.

Pan MR, Wu CC, Kan JY, Li QL, Chang SJ, Wu CC, Li CL, Ou-Yang F, Hou MF, Yip HK, Luo CW. Pan MR, et al. Cancers (Basel). 2019 Dec 30;12(1):94. doi: 10.3390/cancers12010094. Cancers (Basel). 2019. PMID: 31905966 Free PMC article.

10

Curcumol Suppresses Triple-negative Breast Cancer Metastasis by Attenuating Anoikis Resistance via Inhibition of Skp2-mediated Transcriptional Addiction.

Li CL, Huang CW, Ko CJ, Fang SY, Ou-Yang FU, Pan MR, Luo CW, Hou MF. Li CL, et al. Among authors: pan mr. Anticancer Res. 2020 Oct;40(10):5529-5538. doi: 10.21873/anticanres.14565. Anticancer Res. 2020. PMID: 32988876

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters